Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Kiniksa Pharmaceuticals International, plc
| Metric | Kiniksa Pharmaceuticals International, plc KNSAHealthcare |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $678M |
| Net income (latest) | $59M |
| Operating margin | 11.4% |
| Net margin | 8.7% |
| Return on equity | 10.4% |
| Return on assets | 7.7% |
| Return on capital (ROCE) | 12.4% |
| Debt / equity | 0.35× |
| Revenue growth (YoY) | 60.1% |
| Altman Z″ (distress) | 5.08 |
| Accruals / assets | −10.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.